tiprankstipranks
Trending News
More News >
AbCellera Biologics (ABCL)
NASDAQ:ABCL
US Market

AbCellera Biologics (ABCL) Cash flow

Compare
2,253 Followers

AbCellera Biologics Cash Flow

ABCL's free cash flow for Q3 2025 was $-61.52M. For the 2025 fiscal year, ABCL's free cash flow was decreased by $-65.57M and operating cash flow was $-52.59M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -108.56M$ -43.88M$ 277.36M$ 244.58M$ 22.69M
Investing Cash Flow
$ 121.41M$ -221.11M$ -352.63M$ -332.25M$ -119.78M
Financing Cash Flow
$ 12.77M$ 10.36M$ -1.63M$ -3.89M$ 683.65M
End Cash Position
$ 183.62M$ 160.61M$ 414.65M$ 501.14M$ 594.12M
Free Cash Flow
$ -186.95M$ -121.38M$ 204.70M$ 186.13M$ 8.02M
Currency in USD

AbCellera Biologics Cash Flow